242 related articles for article (PubMed ID: 8024275)
1. A novel bullous pemphigoid antigen (BP125) located in the deeper layers of the basement membrane zone.
Gao SQ; Bystryn JC
Arch Dermatol; 1994 Jul; 130(7):873-8. PubMed ID: 8024275
[TBL] [Abstract][Full Text] [Related]
2. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
[TBL] [Abstract][Full Text] [Related]
3. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
Zhu XJ; Niimi Y; Bystryn JC
J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
[TBL] [Abstract][Full Text] [Related]
4. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
Seishima M; Izumi T; Kitajima Y
Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
[TBL] [Abstract][Full Text] [Related]
5. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
[TBL] [Abstract][Full Text] [Related]
6. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
Allen J; Shears E; Powell J; Wojnarowska F
Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
Gao SQ; Bystryn JC
J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
[TBL] [Abstract][Full Text] [Related]
8. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
Labib RS; Anhalt GJ; Patel HP; Mutasim DF; Diaz LA
J Immunol; 1986 Feb; 136(4):1231-5. PubMed ID: 2418109
[TBL] [Abstract][Full Text] [Related]
9. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin.
Onodera Y; Shimizu H; Hashimoto T; Ishiko A; Ebihara T; Tanaka M; Nishikawa T
J Invest Dermatol; 1994 May; 102(5):686-90. PubMed ID: 8176249
[TBL] [Abstract][Full Text] [Related]
10. Identification of basement membrane zone antigens defined by antibodies that react to both the epidermal and dermal side of 1 M sodium chloride split skin.
Niimi Y; Zhu ZX; Bystryn JC
J Invest Dermatol; 1991 Aug; 97(2):312-7. PubMed ID: 1712821
[TBL] [Abstract][Full Text] [Related]
11. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen.
Murakami H; Amagai M; Higashiyama M; Hashimoto K; Chorzelski TP; Bhogal BS; Jenkins RE; Black MM; Zillikens D; Nishikawa T; Hashimoto T
J Dermatol Sci; 1996 Nov; 13(2):112-7. PubMed ID: 8953410
[TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of antibody to 230 kDa bullous pemphigoid antigen in lichen planus-like keratosis.
Seishima M; Izumi T; Kanoh H; Kitajima Y
Eur J Dermatol; 1999; 9(5):393-6. PubMed ID: 10417446
[TBL] [Abstract][Full Text] [Related]
14. A 230-kD basic protein is the major bullous pemphigoid antigen.
Mueller S; Klaus-Kovtun V; Stanley JR
J Invest Dermatol; 1989 Jan; 92(1):33-8. PubMed ID: 2462597
[TBL] [Abstract][Full Text] [Related]
15. Identification of cicatricial pemphigoid antigens.
Niimi Y; Zhu XJ; Bystryn JC
Arch Dermatol; 1992 Jan; 128(1):54-7. PubMed ID: 1739288
[TBL] [Abstract][Full Text] [Related]
16. A case of bullous pemphigoid with antidesmoplakin autoantibodies.
Watanabe K; Hashimoto T; Ishiko A; Shimizu H; Nishikawa T
Dermatology; 1994; 189 Suppl 1():126-8. PubMed ID: 8049553
[TBL] [Abstract][Full Text] [Related]
17. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens.
Robledo MA; Kim SC; Korman NJ; Stanley JR; Labib RS; Futamura S; Anhalt GJ
J Invest Dermatol; 1990 Jun; 94(6):793-7. PubMed ID: 2192002
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
Domloge-Hultsch N; Utecht L; James W; Yancey KB
Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
[TBL] [Abstract][Full Text] [Related]
19. [Molecular heterogeneity of the bullous pemphigoid antigen as detected by immunoblotting].
Izumi H; Hosokawa H
Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):871-5. PubMed ID: 2685419
[TBL] [Abstract][Full Text] [Related]
20. Anatomical distribution and immunological characteristics of epidermolysis bullosa acquisita antigen and bullous pemphigoid antigen.
Furue M; Iwata M; Tamaki K; Ishibashi Y
Br J Dermatol; 1986 Jun; 114(6):651-9. PubMed ID: 3521710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
